UK Consumer Financial Behaviour in a Cost of Living Crisis
There were very few industries that weren’t affected by the COVID-19 pandemic, and the UK finance industry was no exception. Driven by restrictions on physical locations, the industry as a…
Euro industrial output up in August, but sharply down year-on-year By Reuters
© Reuters. FILE PHOTO: A worker stands next to a machine cutting newly manufactured bars of steel at the United Cast Bar Group's foundry in Chesterfield, Britain, April 12, 2022.…
Euro Area industrial production falls 5.1% in August
nito100 Industrial production in the Euro Area fell more than expected in August, decreasing 5.1% over the same month in the previous year. On a monthly basis, industrial production…
Agent Lawsuit Ends in Settlement & Why Dave Ramsey Thinks You Should Sell
The real estate commission lawsuit that threatened buyer’s agents’ income is coming to an end. The conclusion? There could be even more murkiness ahead, and agent commissions are far from…
European markets ease as caution prevails before U.S. bank earnings (EROTF)
London +0.1% Germany -0.2% France -0.1% France inflation rate unchanged at 4.9% in September Spain September final CPI +3.5% vs +3.5% y/y prelim Switzerland September producer and import prices -0.1%…
Here’s the 2-year dividend forecast for Vodafone!
Image source: Getty Images Coming up with a dividend forecast for Vodafone (LSE:VOD) appears straightforward. For the past five financial years, the annual return to shareholders has been 9 euro…
Superfan platform Fave raises $2m in strategic funding from Warner Music, Sony Music and more
The race to monetize music superfans is heating up, and one of the lead startups in the field says it’s in the process of raising millions more for its AI-powered…
mcx stock target: Momentum Pick: MCX jumps 11% in 5 sessions, 70% from 52-week lows. Is there more upside left?
An analysis of the price action suggests that MCX stock has gained 70% from its 52-week lows of Rs 1,285.05, which it hit in May this year. Moreover, despite the…
Ocean Biomedical forms JV with Virion Therapeutics to find treatments for cancer and chronic infectious diseases
Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) entered into a joint venture with Virion Therapeutics, LLC, to expedite and expand the latter’s clinical-stage program and pipeline, with the goal of…
